Whitney Ijem
Stock Analyst at Canaccord Genuity
(4.51)
# 1,066
Out of 5,074 analysts
429
Total ratings
40.4%
Success rate
12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GUTS Fractyl Health | Reiterated: Buy | $96 → $39 | $1.13 | +3,351.33% | 19 | Oct 20, 2026 | |
| MAZE Maze Therapeutics | Initiated Coverage: Buy | $75 | $31.95 | +134.74% | 1 | Oct 19, 2026 | |
| QNRX Quoin Pharmaceuticals | Initiated Coverage: Buy | $18 | $4.01 | +348.88% | 1 | Oct 19, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $114 | $56.63 | +101.31% | 24 | Oct 16, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $78 | $24.56 | +217.59% | 8 | Oct 14, 2026 | |
| PHAR Pharming Group | Reiterated: Buy | $38 | $10.67 | +256.14% | 7 | Oct 14, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $10 | $2.31 | +332.90% | 24 | Oct 7, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $106 | $68.12 | +55.61% | 3 | Oct 6, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $43 → $42 | $3.35 | +1,153.73% | 16 | Oct 5, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $11 | $0.79 | +1,292.41% | 8 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.73 | +86.39% | 31 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $442 | $535.17 | -17.41% | 40 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $39 | $15.95 | +144.51% | 27 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $303 | $150.27 | +101.64% | 1 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $429 | $227.28 | +88.75% | 37 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $166 | $24.28 | +583.69% | 6 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $4.01 | +324.47% | 26 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $11.16 | +339.07% | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.388 | +1,188.66% | 25 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $227 → $232 | $126.39 | +83.56% | 22 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $151 → $154 | $90.90 | +69.42% | 31 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $3.51 | +555.27% | 15 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $114 | $320.13 | n/a | 5 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $18.18 | n/a | 2 | Sep 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $157.19 | n/a | 4 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $116.93 | n/a | 1 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $23.11 | n/a | 4 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $27 | $83.10 | n/a | 2 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 | $0.115 | n/a | 5 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $49.99 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $2.49 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $21.09 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $16 | $0.5461 | n/a | 5 | May 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.04 | n/a | 2 | Jan 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.20 | n/a | 1 | May 13, 2014 |
Fractyl Health
Oct 20, 2026
Reiterated: Buy
Price Target: $96 → $39
Current: $1.13
Upside: +3,351.33%
Maze Therapeutics
Oct 19, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $31.95
Upside: +134.74%
Quoin Pharmaceuticals
Oct 19, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $4.01
Upside: +348.88%
BioMarin Pharmaceutical
Oct 16, 2026
Reiterated: Buy
Price Target: $114
Current: $56.63
Upside: +101.31%
Beam Therapeutics
Oct 14, 2026
Reiterated: Buy
Price Target: $78
Current: $24.56
Upside: +217.59%
Pharming Group
Oct 14, 2026
Reiterated: Buy
Price Target: $38
Current: $10.67
Upside: +256.14%
Rocket Pharmaceuticals
Oct 7, 2026
Reiterated: Buy
Price Target: $10
Current: $2.31
Upside: +332.90%
BridgeBio Pharma
Oct 6, 2026
Reiterated: Buy
Price Target: $106
Current: $68.12
Upside: +55.61%
Wave Life Sciences
Oct 5, 2026
Reiterated: Buy
Price Target: $43 → $42
Current: $3.35
Upside: +1,153.73%
Ocugen
Sep 29, 2026
Reiterated: Buy
Price Target: $11
Current: $0.79
Upside: +1,292.41%
Sep 24, 2026
Reiterated: Buy
Price Target: $20
Current: $10.73
Upside: +86.39%
Sep 23, 2026
Reiterated: Hold
Price Target: $442
Current: $535.17
Upside: -17.41%
Sep 18, 2026
Reiterated: Buy
Price Target: $37 → $39
Current: $15.95
Upside: +144.51%
Sep 4, 2026
Initiated Coverage: Buy
Price Target: $303
Current: $150.27
Upside: +101.64%
Aug 28, 2026
Reiterated: Buy
Price Target: $429
Current: $227.28
Upside: +88.75%
Aug 12, 2026
Reiterated: Buy
Price Target: $180 → $166
Current: $24.28
Upside: +583.69%
Aug 11, 2026
Reiterated: Buy
Price Target: $17
Current: $4.01
Upside: +324.47%
Aug 6, 2026
Reiterated: Buy
Price Target: $49
Current: $11.16
Upside: +339.07%
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $0.388
Upside: +1,188.66%
Aug 5, 2026
Reiterated: Buy
Price Target: $227 → $232
Current: $126.39
Upside: +83.56%
Aug 5, 2026
Reiterated: Buy
Price Target: $151 → $154
Current: $90.90
Upside: +69.42%
Apr 21, 2026
Reiterated: Buy
Price Target: $23
Current: $3.51
Upside: +555.27%
Feb 28, 2022
Reiterated: Buy
Price Target: $83 → $114
Current: $320.13
Upside: n/a
Sep 15, 2021
Upgraded: Buy
Price Target: n/a
Current: $18.18
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $157.19
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $116.93
Upside: n/a
Jun 25, 2020
Reiterated: Hold
Price Target: n/a
Current: $23.11
Upside: n/a
Dec 16, 2019
Reiterated: Buy
Price Target: $18 → $27
Current: $83.10
Upside: n/a
Nov 9, 2018
Downgraded: Hold
Price Target: $18
Current: $0.115
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $49.99
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $2.49
Upside: n/a
Oct 9, 2018
Initiated Coverage: Buy
Price Target: $35
Current: $21.09
Upside: n/a
May 4, 2017
Reiterated: Buy
Price Target: $19 → $16
Current: $0.5461
Upside: n/a
Jan 11, 2017
Reiterated: Hold
Price Target: n/a
Current: $3.04
Upside: n/a
May 13, 2014
Reiterated: Hold
Price Target: n/a
Current: $3.20
Upside: n/a